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Abstract
Proton magnetic resonance (MR) imaging to quantify regional ventilation–perfu-
sion (V̇A∕Q̇) ratios combines specific ventilation imaging (SVI) and separate proton 
density and perfusion measures into a composite map. Specific ventilation imaging 
exploits the paramagnetic properties of O2, which alters the local MR signal inten-
sity, in an FIO2-dependent manner. Specific ventilation imaging data are acquired 
during five wash-in/wash-out cycles of breathing 21% O2 alternating with 100% O2 
over ~20 min. This technique assumes that alternating FIO2 does not affect V̇A∕Q̇ 
heterogeneity, but this is unproven. We tested the hypothesis that alternating FIO2 
exposure increases V̇A∕Q̇ mismatch in nine patients with abnormal pulmonary gas 
exchange and increased V̇A∕Q̇ mismatch using the multiple inert gas elimination 
technique (MIGET).The following data were acquired (a) breathing air (baseline), 
(b) breathing alternating air/100% O2 during an emulated-SVI protocol (eSVI), and 
(c) 20 min after ambient air breathing (recovery). MIGET heterogeneity indices of 
shunt, deadspace, ventilation versus V̇A∕Q̇ ratio, LogSDV̇ , and perfusion versus 
V̇A∕Q̇ ratio, LogSDQ̇ were calculated. LogSDV̇  was not different between eSVI and 
baseline (1.04 ± 0.39 baseline, 1.05 ± 0.38 eSVI, p = .84); but was reduced com-
pared to baseline during recovery (0.97 ± 0.39, p = .04). There was no significant 
difference in LogSDQ̇ across conditions (0.81 ± 0.30 baseline, 0.79 ± 0.15 eSVI, 
0.79 ± 0.20 recovery; p = .54); Deadspace was not significantly different (p = .54) 
but shunt showed a borderline increase during eSVI (1.0% ± 1.0 baseline, 2.6% ± 2.9 
eSVI; p = .052) likely from altered hypoxic pulmonary vasoconstriction and/or ab-
sorption atelectasis. Intermittent breathing of 100% O2 does not substantially alter 
V̇A∕Q̇ matching and if SVI measurements are made after perfusion measurements, 
any potential effects will be minimized.
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1 |  INTRODUCTION
Many lung diseases are characterized by an increase in ven-
tilation–perfusion (V̇A∕Q̇) mismatch, which impairs pulmo-
nary gas exchange. Our laboratory has developed a proton 
magnetic resonance imaging (MRI) technique, to measure re-
gional ventilation-perfusion mismatch, which combines spe-
cific ventilation imaging (SVI) with proton density (Holverda 
et  al.,  2011; Theilmann et  al.,  2009) and perfusion (Bolar 
et al., 2006) images to give regional V̇A∕Q̇ ratios (Henderson 
et al., 2013; Sá et al., 2017).
Specific ventilation imaging noninvasively measures re-
gional specific ventilation (Sá et al., 2010, 2014). During SVI, 
the subject breathes 20 breaths of 100% O2 (~2 min, washin) 
followed by 20 breaths of air (~2 min, washout) and repeats 
this alternating block five times. Oxygen is paramagnetic; by 
breathing 100% O2 and using an appropriate magnetic reso-
nance sequence, inhaled O2 is used as an MRI contrast agent 
(Sá et al., 2010, 2014). By analyzing the time course of the 
change in MR signal intensity on a voxel by voxel basis, a 
specific ventilation map is constructed (Sá et al., 2010, 2014), 
and then combined with density and perfusion measures.
Although it is a common tool in pulmonary function test-
ing, (Comroe & Fowler, 1951; Fowler, 1949; Lewis, Evans, 
& Jalowayski,  1978; Martin, Tsunoda, & Young,  1974; 
Robinson et al., 2013; Verbanck et al., 1997, 1998), breathing 
hyperoxic gas could affect the underlying pulmonary physiol-
ogy and V̇A∕Q̇ matching. For example, O2 breathing can alter 
regional blood flow and ventilation predominately by either 
the release of hypoxic pulmonary vasoconstriction and/or ab-
sorption atelectasis (Dawson, 1969, 1984; Lee & Read, 1967; 
Morrell, Nijran, Biggs, & Seed,  1994), but other mecha-
nisms can also modulate these processes. Hyperoxia can 
either directly or indirectly alter bronchomotor tone (Astin 
& Penman, 1967; Libby, Briscoe, & King, 1981), which in 
turn potentially increases V̇A∕Q̇ heterogeneity (Robinson, 
Freiberg, Regnis, & Young,  2000; Sassoon, Hassell, & 
Mahutte,  1987). Additionally, hyperoxia, due to its effects 
on blood flow and/or ventilatory drive (Aubier et al., 1980; 
Robinson et al., 2000; Sassoon et al., 1987) may alter local 
alveolar CO2 which may in turn affect local lung mechan-
ics and ventilation (Emery, Eveland, Kim, Hildebrandt, 
& Swenson,  2007; Emery, Eveland, Min, Hildebrandt, & 
Swenson,  2013; Traystman, Batra, & Menkes,  1976), and 
thus the underlying V̇A∕Q̇ distribution.
The effect of intermittent hyperoxia, as used in pro-
ton MRI evaluation of V̇A∕Q̇ relationships, on V̇A∕Q̇ mis-
match is unknown. Previously we showed that in healthy 
subjects, exposure to either hyperoxia or hypoxia did not 
affect ventilation heterogeneity (Hopkins, Elliott, Prisk, & 
Darquenne,  2017), but in healthy subjects any underlying 
V̇A∕Q̇ mismatch is expected to be minimal and thus potential 
changes may be minimized. In the present study, we evaluated 
the effect of an emulated SVI (eSVI) O2 breathing protocol 
on V̇A∕Q̇ heterogeneity in nine subjects with a clinical diag-
nosis of COPD. This subject population was chosen because 
they could reasonably be expected to show V̇A∕Q̇ mismatch 
at baseline. We hypothesized that an eSVI protocol would in-
crease V̇A∕Q̇ heterogeneity consistent with underlying effects 
of O2 either on hypoxic pulmonary vasoconstriction or by al-
tering the ventilation distribution or a combination of both. 
To test this, we measured V̇A∕Q̇ mismatch with the multiple 
inert gas elimination technique (MIGET) (Hlastala,  1984; 
Hlastala & Robertson, 1978; Roca & Wagner, 1994; Wagner, 
Naumann, & Laravuso, 1974), a well-established method for 
quantitatively assessing V̇A∕Q̇ matching.
2 |  METHODS
2.1 | Subjects
This study was approved by the University of California, 
San Diego's Human Subjects’ Research Protection Program. 
Subjects were recruited via advertisements, pulmonary clin-
ics, and existing research databases. Recruited subjects all 
had a diagnosis of COPD made by their personal physician, 
and all had a significant history of cigarette smoking (20 ± 12 
pack-years). All subjects gave written informed consent prior 
to participating. Recruited subjects were screened with a 
medical questionnaire for assessment of exclusion criteria 
that included any history of significant illness aside from a 
diagnosis of COPD or a current history of a recent exacerba-
tion. Nine subjects, seven males and two females, between 
49 and 70 years old participated. Subjects remained on their 
daily medication such as long-acting bronchodilators and 
inhaled steroids for the study. Eight subjects completed the 
entire protocol; and one individual, subject #7, declined to 
complete the recovery portion of the study because of time 
constraints.
2.2 | Overall study design
On the day of the study, all subjects underwent spirometry 
using an EasyOne spirometer (ndd Medical Technologies, 
K E Y W O R D S
hyperoxia, magnetic resonance imaging, pulmonary perfusion distribution, pulmonary ventilation 
distribution, specific ventilation imaging, ventilation-perfusion ratio
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Zurich, Switzerland). To assess the influences of alternating 
FIO2 concentrations on V̇A∕Q̇ heterogeneity, subjects were 
studied using MIGET during three conditions: (a) steady-
state quiet breathing of ambient air, baseline; (b) at the end of 
eSVI which consisted of alternating breathing air for 2 min 
followed by 2 min of 100% O2 for a total of 20 min; and (c) 
after a 20-min period of air breathing, recovery (Figure 1). 
During the eSVI section of the protocol, to maximize the 
chance of seeing potential effects of FIO2 on the V̇A∕Q̇ dis-
tribution, data and samples were acquired during the last two 
blocks (14–16 and 18–20 min) of 100% O2 breathing.
2.3 | MIGET protocol
2.3.1 | Experimental setup
The subjects were supine for the study duration duplicating 
the necessary posture of subjects during SVI MRI data acqui-
sition. The nondominant arm radial artery was catheterized 
using a 20 gauge, 1.25” catheter, for the collection of arterial 
blood samples, and for direct arterial pressure monitoring. A 
peripheral vein from the contralateral arm was catheterized 
with an 18 gauge, 2” catheter for the infusion of 5% dextrose 
solution containing the inert gas mixture. Body temperature 
was measured using an oral thermometer. ECG and cardiac 
output were monitored with a tetrapolar impedance cardio-
graph (model BioZ ICG, CardioDynamics), which was previ-
ously validated against direct Fick measures of cardiac output 
(Yung, Fedullo, Kinninger, Johnson, & Channick, 2004).
2.3.2 | Multiple inert gas elimination  
technique
The multiple inert gas elimination technique has been pre-
viously described in detail (Wagner, Laravuso, Uhl, & 
West,  1974; Wagner, Saltzman, & West,  1974), therefore 
is only briefly described here. Maintaining sterility, the six 
usual MIGET inert gases, (sulfur hexafluoride, ethane, cy-
clopropane, enflurane, ether, and acetone) were dissolved in 
5% dextrose. This solution was continuously infused intrave-
nously for the entire study duration at a rate of 2–5 ml/min. 
The rate was selected based on the subject's minute ventila-
tion, at approximately 1 ml/min per 2 L/min ventilation, and 
has been shown to provide adequate signal to noise in the 
measurement of all inert gas levels. The infusion was started 
30 min prior to baseline measurements to ensure steady-state 
conditions for inert gases. From the last 10 min onward, the 
subject breathed on a mouthpiece into a heated nonrebreath-
ing valve (model 2700, Hans Rudolph Inc) that was con-
nected to a heated (~45°C) low resistance expired gas mixing 
box. Steady-state conditions were confirmed by ensuring sta-
ble inert gas infusion, ventilation, and cardiac output prior to 
and during measurements.
2.3.3 | Sampling protocol
For each condition (baseline, eSVI, recovery), mixed expired 
O2 and CO2 concentrations were continuously sampled and 
measured from the mixing box using a mass spectrometer 
(Perkin Elmer, MGA 1100) and recorded using data acqui-
sition software (LabView, National Instruments), while si-
multaneously measuring minute ventilation (V̇E) using a 
calibrated gas rotameter (100 Liter, BOC), and mixing box 
temperature. For each condition, the data were averaged to 
calculate O2 consumption, carbon dioxide production, and 
the respiratory exchange ratio (V̇O2, V̇CO2, RER, respec-
tively). Four arterial blood samples (5–7 ml each), and four 
time-aligned mixed expired gas samples (20 ml each) were 
collected for quadruplicate measurement of inert gas levels, 
while simultaneously measuring cardiac output. Immediately 
after each inert gas sample, 2 ml of arterial blood gas sam-
ple was drawn into a preheparinized 3-ml syringe, de-
bubbled, stored on ice, and analyzed with a GEM 3000 
analyzer (Instrumentation Laboratories) to measure PaO2, 
PaCO2, pHa, hematocrit, hemoglobin, and O2 saturation. The 
F I G U R E  1  MIGET protocol sequence 
for data collection and sampling
4 of 11 |   ELLIOTT ET aL.
alveolar–arterial PO2 difference (A-aDO2) was derived from 
respiratory data and the corresponding average of the four 
arterial blood gas samples. All measurements were repeated 
during eSVI where the mixed expired gas samples and as-
sociated arterial blood gases were collected in duplicate at 
the end of the last two 100% O2 breathing periods (providing 
a quadruplicate sample set), and in duplicate at the end of a 
20-min recovery air breathing period. V̇O2 and respiratory 
exchange ratio were not calculated at the end of the eSVI be-
cause O2 consumption cannot be accurately measured during 
100% O2 breathing.
Inert gas concentrations were measured in the mixed ex-
pired and arterial blood samples using gas chromatography 
(5890A; Hewlett-Packard) (Wagner, Naumann, et al., 1974). 
Mixed venous concentrations of the inert gases were calcu-
lated by the Fick principle. Retention-solubility and excre-
tion-solubility curves were generated for the six gases in 
each sample and transformed into a continuous plot of per-
fusion against V̇A∕Q̇ and ventilation against V̇A∕Q̇ using the 
50-compartment model (Wagner, Saltzman, et al., 1974). The 
residual sum of squares (RSS) for the measured 6-gas data 
and the least squares best fit to the 50 compartment model 
was calculated for each data set (Hopkins & Wagner, 2017). 
The degree of mismatch was determined by calculating the 
second moments, about their mean, of the perfusion and ven-
tilation distributions, on a log V̇A∕Q̇ scale excluding shunt 
and deadspace compartments, which are evaluated sepa-
rately. The second moments are termed LogSDQ̇ represent-
ing heterogeneity of the perfusion versus V̇A∕Q̇ distribution, 
and LogSDV̇  representing heterogeneity of the ventilation 
versus V̇A∕Q̇ distribution.
2.4 | Statistical analysis
Statistical analyses were performed using KaleidaGraph 
(v4.5, Synergy Software). ANOVA for repeated measures 
was used to evaluate differences between baseline, eSVI, and 
recovery for all indices derived from MIGET, ventilation, 
and blood gas data. Where overall significance occurred, 
post hoc testing was conducted using a two-tailed Student's 
t test to evaluate differences between the three conditions. 
Significance was accepted at p < .05. All data are expressed 
as mean ± standard deviation.
3 |  RESULTS
3.1 | Subject demographics
All subjects tolerated the study well. The subjects’ demo-
graphics, spirometric and blood gas data are listed in Table 1. 
The extent of pulmonary disease in this population ranged TA
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from very mild to severe based on spirometry with FEV1 per-
cent predicted ranging from 99% to 22%. Three of the subjects 
(Subjects 6, 7, and 8) with self-reported smoking histories 
of 37, 30, and 10 pack years, had relatively normal spirom-
etry, despite their clinical diagnosis of COPD. These three 
subjects had A-aDO2 differences of 35, 29, and 42 mmHg, 
respectively, and LogSDQ̇ values above the normal LogSDQ̇ 
range of 0.3–0.6 (Figure 2). These gas exchange values are 
similar to that of GOLD stage 1 COPD patients (Rodríguez-
Roisin et al., 2009).
3.2 | Metabolic, arterial blood gas data, and 
A-aDO2 (Tables 1 and 2)
Cardiac output,V̇E and V̇CO2 all showed no signifi-
cant differences across baseline, eSVI, and recovery 
(p  =  .69, p  =  .22, and p  =  .61, respectively) confirm-
ing steady-state conditions. V̇O2 cannot be assessed 
during hyperoxic breathing and is not reported, but V̇
O2 was not different between baseline and recovery 
(p  =  .28). At baseline all nine subjects had an abnor-
mally low PaO2 (mean PaO2  =  75.5  ±  5.7  mmHg). PaO2 
showed the expected increase during eSVI, increasing 
to a mean PaO2  =  438  ±  40.5  mmHg (p  <  .0001) com-
pared to baseline and recovery, and PaO2 during the recov-
ery period (83.3  ±  7.1  mmHg) was higher than baseline 
(75.5 ± 5.7 mmHg) (p = .04). Similarly, there was the ex-
pected increase in the SaO2 from baseline (93.4 ± 1.9%) to 
eSVI of 95.7 ± 1.8% (p <  .0001), and the recovery SaO2 
(94.0 ± 1.9%) was also greater (p = .04) than baseline con-
ditions. A-aDO2 cannot be calculated during O2 breathing 
because V̇O2 and respiratory exchange ratio are unknown. 
The baseline and recovery A-aDO2 were elevated in all 
subjects (mean 32  ±  8  mmHg and 30  ±  12  mmHg, re-
spectively), and were not significantly different from each 
other (p  =  .22). PaCO2 was not different between base-
line (37.3  ±  7.0  mmHg) and eSVI (36.3  ±  6.8  mmHg), 
but recovery PaCO2 was significantly lower than baseline 
(34.6 ± 6.7 mmHg, p = .03), suggesting increased alveo-
lar ventilation. There were no significant changes in pHa, 
hemoglobin or hematocrit across all three conditions, 
p = .29, p = .40, and p = .28, respectively.
3.3 | MIGET data
The residual sum of squares (Table 2) were consistent with 
good data quality and adequacy of fit to the model for each 
condition. The RSS values were not different across condi-
tions (p  =  .33). There were no significant differences be-
tween conditions for deadspace ventilation (V̇DS) (p = .54) or 
the means (i.e., first moments) of the ventilation (p = .38) or 
perfusion distributions (p = .90).
Baseline Q̇shunt (Table 2 and Figure 2) showed an small 
increase (1.0 ± 1.0% of cardiac output) compared to negli-
gible values seen in normal subjects (Wagner, Laravuso, 
F I G U R E  2  Individual LogSDQ̇, LogSDV̇ and shunt for the nine 
subjects, at baseline, eSVI, and recovery. LogSDQ̇ = heterogeneity 
of the perfusion versus VA∕Q distribution, LogSDV̇ = heterogeneity 
of the ventilation versus VA∕Q distribution; and Q̇shunt = percent of 
cardiac output to shunt regions (V̇A∕Q̇ < 0.005). #denotes post hoc 
statistical difference between baseline and recovery at p < .05 (two-
tailed t test). Note: normal LogSDQ̇ range of 0.3–0.6; and normal 
LogSDV̇ range 0.3–0.65 (Hopkins & Wagner, 2017)
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et al., 1974), and showed a borderline change across condi-
tions (p = .052) increasing during eSVI to 2.6 ± 2.9%.
Baseline LogSDQ̇ and LogSDV̇  measures of hetero-
geneity were increased above normal values consistent 
with the diagnosis of COPD in these subjects (Rodríguez-
Roisin et  al.,  2009; Wagner, Dantzker, Dueck, Clausen, & 
West,  1977). Figure  2 shows baseline, eSVI and recovery 
LogSDQ̇ and LogSDV̇  and shunt values for all nine subjects. 
Mean LogSDQ̇ was not significantly different across the 
three conditions (0.81 ± 0.22 baseline, 0.79 ± 0.15 eSVI, and 
0.79 ± 0.20 recovery, p = .54). Mean LogSDV̇  of 1.05 ± 0.38 
during eSVI was not significantly different from baseline 
(1.04 ± 0.39, p =  .84), but LogSDV̇  in recovery showed a 
small but statistically significant reduction to 0.97  ±  0.39 
(p = .04) compared to baseline, but it was not significantly 
different than that during eSVI (p = .17).
4 |  DISCUSSION
The principal findings of this study are that in subjects with 
varying degrees of underlying V̇A∕Q̇ mismatch and a clinical 
diagnosis of COPD, there was no significant change in the 
MIGET indices that measure global ventilation and perfusion 
heterogeneity, LogSDV̇ , and LogSDQ̇ compared to base-
line air breathing; the LogSDV̇ , was slightly reduced after 
20 min of air breathing. There was also no significant change 
in deadspace, although there was a borderline increase in 
shunt during the eSVI protocol. These findings suggest that 
changes in V̇A∕Q̇ mismatch during hyperoxic exposure are 
small and that SVI is an appropriate method to use in pro-
ton MR measures of regional V̇A∕Q̇ ratio. However, because 
SVI may potentially cause small changes in pulmonary blood 
flow and/or shunt, we suggest the perfusion imaging always 
Baseline eSVI Recovery
ANOVA 
p
Hb (g/dl) 13.7 ± 2.0 13.6 ± 2.0 13.2 ± 0.3 .40
Hct (%) 43.0 ± 7.0 41.9 ± 6.6 41.1 ± 7.1 .28
Q̇ (l/min) 5.4 ± 0.5 5.3 ± 0.6 5.3 ± 0.5 .69
HR (bts/min) 76 ± 11 71 ± 11 73 ± 11 .03
V̇E (l/min) 8.5 ± 1.4 8.8 ± 1.4 9.0 ± 1.2 .22
V̇O2 (ml/min) 244 ± 40 na 224 ± 47 .28
V̇CO2 (ml/min) 206 ± 42 206 ± 44 205 ± 38 .61
RER (ratio) 0.84 ± 0.06 na 0.92 ± 0.09# .046
SaO2 (%) 93.4 ± 1.9 95.7 ± 1.8* 94.0 ± 1.9#$ <.0001
A-aDO2 (mmHg) 32.4 ± 7.7 na 29.9 ± 11.8 .22
PaO2 (mmHg) 75.5 ± 5.7 438.3 ± 40.5* 83.3 ± 7.1#$ .001
PaCO2 (mmHg) 37.3 ± 7.0 36.3 ± 6.8 34.6 ± 6.7 .03
pHa 7.46 ± 0.05 7.47 ± 0.05 7.47 ± 0.05 .29
RSS 5.26 ± 2.99 5.61 ± 6.22 4.40 ± 4.14 .33
V̇DS (%V̇) 0.36 ± 0.04 0.37 ± 0.07 0.37 ± 0.09 .54
Q̇ Shunt (%Q̇) 1.0 ± 1.0 2.6 ± 2.9 1.8 ± 2.8 .052
Mean V̇ 1.89 ± 0.54 2.03 ± 0.50 1.89 ± 0.36 .38
LogSDV̇ 1.04 ± 0.39 1.05 ± 0.38 0.97 ± 0.39# .050
Mean Q̇ 0.81 ± 0.30 0.83 ± 0.20 0.86 ± 0.24 .90
LogSDQ̇ 0.81 ± 0.22 0.79 ± 0.15 0.79 ± 0.20 .54
Note: p values for ANOVA testing, when significant *denotes post hoc statistical difference between baseline 
and emulated-SVI; and #denotes post hoc statistical difference between baseline and recovery; and $denotes 
post hoc statistical difference between emulated-SVI and recovery. Post hoc significance was accepted at 
p < .05 (-tailed t-test). Note: normal LogSDQ̇ range of 0.3–0.6; and normal LogSDV̇  range 0.3–0.65 (Hopkins 
& Wagner, 2017). (n = 9 except recovery n = 8, mean ± SD).
Abbreviations: Q̇ shunt, percent of cardiac output to shunt regions (V̇A∕Q̇ < 0.005); Q̇, cardiac output; V̇
CO2, carbon dioxide production; V̇E, minute ventilation; V̇O2, oxygen consumption; A-aDO2, alveolar-
arterial difference for oxygen; Hb, hemoglobin; Hct, hematocrit; HR, heart rate; LogSDQ̇, heterogeneity of 
the perfusion versus V̇A∕Q̇ distribution; LogSDV̇ , heterogeneity of the ventilation versus V̇A∕Q̇ distribution; 
mean Q̇, mean of the perfusion distribution; mean V̇ , mean of the ventilation distribution; na, values could not 
be calculated during hyperoxia; PaCO2, arterial carbon dioxide partial pressure; PaO2, arterial oxygen partial 
pressure; pHa, arterial pH; RER, respiratory exchange ratio; RSS, residual sum of squares; SaO2, arterial 
oxygen saturation; V̇DS, percent of ventilation to deadspace (V̇A∕Q̇ > 100).
T A B L E  2  Baseline, eSVI, and 
recovery supine physiologic data
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be performed before SVI so to minimize any protocol impact 
on V̇A∕Q̇ mapping.
4.1 | Subject population and spirometry
In this study, baseline LogSDQ̇ and the LogSDV̇  measures 
of heterogeneity were markedly increased above normal val-
ues consistent with the goal of selecting subjects with un-
derlying V̇A∕Q̇ mismatch and with their diagnosis of COPD 
(Rodríguez-Roisin et al., 2009; Wagner et al., 1977). All sub-
jects demonstrated hypoxemia during baseline air breathing, 
even subjects with very mild air flow obstruction (Table 1). 
The subjects with normal spirometry had significant eleva-
tion in A-aDO2 and V̇A∕Q̇ mismatch (Table 1 and Figure 2), 
which were similar to those subjects with more severe dis-
ease. This is consistent with data from Rodríguez-Roisin 
et al. (2009) who showed that the extent of V̇A∕Q̇ inequal-
ity was poorly correlated with disease severity based on 
spirometry.
4.2 | Potential effects of O2 on the 
distribution of ventilation, perfusion, and 
V̇A∕Q̇ mismatch
The distribution of ventilation is affected by the structural 
heterogeneity of the bronchial and vasculature trees and the 
feedback systems designed to regulate the local V̇A∕Q̇ match-
ing to maximize overall gas exchange. The respiratory gases 
have some regulatory control of bronchomotor tone and the 
degree of effect is based on the size of the affected region and 
local environment of the region, but the effects are small and 
varied (Swenson, Domino, & Hlastala, 1998). Alveolar hy-
poxia has a mild bronchoconstrictive effect as evidenced by 
increases in airway resistance (Saunders et al., 1977; Sterling, 
1968), and this effect may be modulated by local CO2 con-
centrations; in general, hypocapnia enhances bronchoc-
onstriction (Elshout, van Herwaarden, & Folgering,  1991; 
Ingram, 1975; Twort, Neild, & Cameron, 1985) while hyper-
capnia inhibits the increase in collateral airways resistance 
(Traystman et al., 1976). Hyperoxia exposure in healthy sub-
jects has been shown to have little bronchomotor effect when 
looking at changes in maximal expiratory flow rates, airway 
conductances and resistances (Astin & Penman, 1967; Butler, 
Caro, Alcara, & Dubois, 1960; Libby et al., 1981). Consistent 
with this, in healthy subjects, we previously showed that nei-
ther hypoxic (FIO2  =  0.125) nor a hyperoxic (FIO2  =  0.9) 
(Hopkins et al., 2017) exposure altered ventilation heteroge-
neity as measured by the multiple breath washout.
All our subjects were hypoxemic during baseline con-
ditions which was relieved during eSVI. In hypoxemic 
COPD patients, bronchoconstriction can occur (Astin & 
Penman, 1967; Libby et al., 1981) and is reversed by breath-
ing 30% O2; but it is not known if the bronchoconstriction is 
the direct effect of low arterial O2 tensions on the bronchial 
smooth muscle or the reduced lower airway and alveolar O2 
tensions. In the presence of hypoxemia-induced bronchoc-
onstriction, hyperoxic exposure could cause bronchodilation 
causing an increase in regions of high V̇A∕Q̇ ratio or dead-
space (V̇A∕Q̇ >100), but this was not seen in the present study. 
In some COPD patients, hyperoxia has been shown to induce 
hypercapnia (Abdo & Heunks,  2012; Aubier et  al.,  1980; 
Robinson et al., 2000; Sassoon et al., 1987), which is thought 
to be primarily caused by an increase in V̇A∕Q̇ mismatch and 
deadspace. This may be related to the release of hypoxic pul-
monary vasoconstriction, secondary bronchodilatory effects, 
and a decrease in collateral resistance due to the relaxation 
of local parenchymal tissue associated with elevated PaCO2 
due to concurrent hypoventilation. The absence of changes 
in V̇A∕Q̇ matching, deadspace, ventilation, or PaCO2 during 
hyperoxia suggests that this is not a major factor in the pres-
ent study.
One possibility for the borderline increase in shunt is 
absorption atelectasis due to alveolar de-nitrogenation 
(Dantzker, Wagner, & West, 1975). However, it is thought that 
parenchymal interdependence forces of attached neighbor-
ing alveoli and collateral ventilation may counteract the loss 
of volume and preventing alveolar collapse (Briscoe, Cree, 
Filler, Houssay, & Cournand, 1960; Dantzker et al., 1975). In 
COPD, it has been shown that the degree of collateral ven-
tilation increases with disease severity (Hogg, Macklem, & 
Thurlbeck, 1969) and this increase in collateral flow poten-
tially counteracts the development of absorption atelectasis 
and increase shunt (Barberà et al., 1996; Santos et al., 2000). 
In some COPD subjects, hyperoxia worsens V̇A∕Q̇ match-
ing resulting in an increase in the number of low V̇A∕Q̇ units 
but with little or no increase in shunt (Barberà et al., 1996; 
Rodriguez-Roisin,  2014; Santos et  al.,  2000). This is the 
case for the majority of subjects in the present study, and 
the reversibility argues against atelectasis as a mechanism. 
However, the response of subject #8 suggests the possibility 
of absorption atelectasis in this individual because the shunt 
did not resolve during recovery, although the changes were 
small.
Hyperoxia may release hypoxic pulmonary vasocon-
striction resulting in a deterioration of V̇A∕Q̇ matching by 
increasing pulmonary blood flow to poorly ventilated or 
shunt regions. The time course of hypoxic pulmonary vaso-
constriction during severe regional hypoxia has been shown 
to have different profiles based on the type of preparations 
or protocols, species studied, and global versus regional 
exposure (Sylvester, Shimoda, Aaronson, & Ward,  2012; 
Talbot, Balanos, Dorrington, & Robbins, 2005). In general, 
the hypoxic pulmonary vasoconstrictor response to global 
hypoxia has an initial rapid onset profile (within seconds) 
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that reaches a maximum by 30 min, followed by a second-
ary gradual increase over the next 2  hr. The relaxation of 
the hypoxia induced vasoconstriction is less clear. In hu-
mans, 25 min of isocapnic hypoxia exposure causes a rapid 
rise followed by a plateau in pulmonary vascular resistance, 
which subsequently after 5 min of normoxia returns to base-
line (Talbot et al., 2005). However, with a longer isocapnic 
hypoxia exposure (105 min), pulmonary vascular resistance 
rapidly reached a plateau then slowly continued to rise, but 
took longer than 10 min to return to baseline. This suggests 
that the relaxation response with the removal of a hypoxic 
stimulus may follow a different time profile than the activa-
tion process. The lack of marked changes in the present study 
may simply be because the hyperoxic exposure was too short 
(10 min in total) and intermittent.
There is evidence that structural changes, and thickening 
of the intimal layer of the pulmonary muscular arteries may 
affect the ability of the pulmonary vasculature to respond to 
changes in O2 and thus hypoxic pulmonary vasoconstriction 
(Barberà et al., 1994). Work in healthy subjects and in stable 
mild to severe COPD subjects which used MIGET before and 
after breathing 100% O2 for >30 min, (Barbera et al., 1990; 
Barberà et al., 1994; Wagner et al., 1977; Wagner, Laravuso, 
et  al.,  1974) showed no change in either in LogSDQ̇, and 
LogSDV̇  and no change in deadspace in healthy and some 
COPD subjects. However, other COPD subjects showed an 
increase in LogSDQ̇, and increased perfusion to regions of 
low V̇A∕Q̇. This variability between COPD subjects was at-
tributed to the degree of vascular remodeling associated with 
disease progression (Barberà et  al.,  1994). Consistent with 
this, two of our subjects with normal spirometry #6 and #8, 
(Figure  2), who had the largest increase in shunt with hy-
peroxia, had a conversion of existing low V̇A∕Q̇ into shunt 
during eSVI, which was reversed in recovery. The subjects 
with more severe airway obstruction (subjects 1–5, 9) showed 
no change in low V̇A∕Q̇ units and no increase in shunt with 
hyperoxia which agrees with other studies with subjects with 
advanced airway obstruction (Barberà et  al.,  1996; Santos 
et al., 2000). Thus, in this study, the cyclic two-minute inter-
mittent exposures to hyperoxia during SVI are short enough 
that it is unlikely that complete release of hypoxic pulmo-
nary vasoconstriction occurs during the hyperoxia exposure. 
This is even less likely in COPD patients if they have lower 
vascular responsiveness to changes in O2 concentrations. 
Consequently, this is likely why, on average, we observed 
minimal changes in the LogSDV̇  and LogSDQ̇.
4.3 | Post eSVI recovery and ventilation and 
perfusion heterogeneity
At the end of the recovery period, there was a small but sig-
nificant reduction in LogSDV̇  compared to baseline; while 
LogSDQ̇ remained unchanged. The respiratory exchange 
ratio was significantly increased from 0.84  ±  0.06 during 
baseline to 0.92 ± 0.09 during recovery (p = .046), associ-
ated with a small decrease in PaCO2. This small increase in 
ventilation, possibly due to subject discomfort over the study 
course (~2  hr), may be partly responsible for the increase 
in PAO2 and PaO2 in recovery. The resulting V̇A∕Q̇ distri-
bution during recovery showed a minor shift toward higher 
V̇A∕Q̇ units compared to baseline. Therefore, the slight im-
provement in gas exchange after recovery was probably due 
to a combination of factors, including increased ventilation, 
small reduction in ventilation–perfusion mismatch and return 
of hypoxic pulmonary vasoconstriction, none of which were 
statically significant on their own.
4.4 | Limitations
MIGET is a method that measures pulmonary gas exchange 
by recovering the global V̇A∕Q̇ distribution from excretion 
and retention patterns of six infused inert gases, thus provid-
ing an overall index of V̇A∕Q̇ heterogeneity. Because of the 
global nature of the MIGET results, we cannot identify if 
there are any regional perfusion or ventilation heterogene-
ity changes occurring during hyperoxia that were counter-
balanced by opposing changes in other regions. We studied 
a small number of subjects; thus, the generalizability of the 
findings is limited by how well the population studied is repre-
sentative population as a whole. When statistical significance 
is lacking, the study statistical power must be considered, 
since a small number of subjects may impair the ability to 
detect meaningful differences. This study used a repeated 
measures design, thus each subject is their own control, and 
MIGET indices are highly reliable (test retest correlation ~.9 
(Wagner, Hedenstierna, Bylin, & Lagerstrand,  1987)). For 
the observed differences in LogSDV̇  and LogSDQ̇ between 
baseline and eSVI to be statistically significant (p < .05, two-
tailed) in a larger sample, post hoc power calculations reveal 
that at least 2,338 and 228 subjects, respectively, would be 
required. Thus, any difference between conditions is biologi-
cally very small.
As a quality control step, MIGET retention data were 
matched by a fitting process, the sum of squares of the six 
gas residuals, and this RSS for all three conditions was cal-
culated. The cumulative chi-square distribution (six degrees 
of freedom) predicts a mean RSS of 5.3 (50th percentile) and 
10.6 (90th percentile) to be indicative of an adequate data fit 
for the 50 compartment model (Hopkins & Wagner, 2017). 
Baseline, eSVI and recovery RSS were 5.3 ± 3.0, 5.6 ± 6.2, 
and 4.4 ± 4.1, respectively, thus demonstrating adequate data 
quality and supports existence of steady-state conditions. The 
mean RSS for all three conditions were not statistically dif-
ferent from each other, suggesting that alternating FIO2 did 
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not disturb gas exchange for MIGET gases to any identifiable 
degree.
5 |  CONCLUSIONS
We did not find evidence that alternating inspired O2 con-
centration between 21% and 100% for five cycles for 20 min 
affects V̇A∕Q̇ heterogeneity in subjects with lung disease in 
physiologically significant ways. Results from this study 
suggest that intermittent hyperoxia exposure that occurs dur-
ing SVI which is used to calculate of regional V̇A∕Q̇ with 
proton MRI has a minimal effect on V̇A∕Q̇ heterogeneity as 
measured by MIGET. Accordingly, we suggest that the as-
sumption of insignificant effects on V̇A∕Q̇ relationships due 
to SVI protocol is reasonable, supporting its use as part of 
a methodology to evaluate V̇A∕Q̇ inequality noninvasively. 
Nevertheless, given the findings, collection of perfusion data, 
which does not require altering FIO2, is recommended before 
performing SVI.
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